Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoids, Learning, and Memory
NCT02407808Phase 1Active, not recruiting
- Sponsor
- Yale University
- Start
- Feb 2015
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of dronabinol (2 arms), sponsored by Yale University. Primary endpoints: Rey Auditory Verbal Learning Test and N-Back Task. Started Feb 2015; status: active, not recruiting.
02
Drugs
dronabinol
Beyond the preview
Go deeper on NCT02407808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02407808.